Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine versus esketamine combined with sufentanil for postoperative analgesia after laparoscopic cholecystectomy
ChiCTR2300072011Phase 4Not yet recruiting
- Sponsor
- Zigong Traditional Chinese Medicine Hospital
- Start
- May 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, dezocine and sufentanil in postoperative pain (2 arms), sponsored by Zigong Traditional Chinese Medicine Hospital. Primary endpoint: Visual Analogue Scale pain scores. Planned start May 2023; status: not yet recruiting.
02
Drugs
esketaminedezocinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300072011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072011.